Understanding How Movements Are Transferred From Task to Task in Parkinson's Disease
Neural Mechanism of Skill Transfer in Parkinson's Disease
1 other identifier
interventional
24
1 country
1
Brief Summary
The purpose of this study is to understand how a specific brain area, the Posterior Parietal Cortex (PPC), plays a role in movement transfer from walking on a split-belt treadmill (SBT) to walking on the ground in people with Parkinson's disease (PwPD). Here, investigators will apply repeated transcranial magnetic stimulation (rTMS) to upregulate the PPC. Then, the differences in the gait parameters between pre- and post-interventions will be compared between the TMS-active and the TMS-sham.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2025
CompletedStudy Start
First participant enrolled
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedJanuary 20, 2026
January 1, 2026
5 months
September 26, 2025
January 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Stride length
The forward distance travelled by a foot during a gait cycle (cm) measured during overground walking and on the SBT with the Ambulatory Parkinson's Disease Monitoring (APDM) mobility lab system. A higher score indicates better gait control.
Day 2 and Day 3
Dual Support
The percentage of the gait cycle when both feet are in contact with the ground (%) will be measured during overground walking and on the SBT with the Ambulatory Parkinson's Disease Monitoring (APDM) mobility lab system. A higher score indicates a longer time for both feet to be in contact with the ground.
Day 2 and Day 3
Secondary Outcomes (6)
Cadence
Day 2 and Day 3
Gait Speed
Day 2 and Day 3
Turning Velocity
Day 2 and Day 3
Steps in turn
Day 2 and Day 3
Step length
Day 2 and Day 3
- +1 more secondary outcomes
Study Arms (2)
Active rTMS First followed by Sham rTMS Second
OTHERSession 1: active rTMS (iTBS) over the right PPC Session 2: sham rTMS (iTBS) over the right PPC
Sham rTMS First followed by Active rTMS Second
OTHERSession 1: sham rTMS (iTBS) over the right PPC Session 2: active rTMS (iTBS) over the right PPC
Interventions
SHAM: 2 coils on top of each other will be used instead of 1. The coil furthest to the head will be reversed. The coil on the head will not be stimulating but the reversed coil will (current directed away from the brain) with stimulate with the same parameters at the active stimulation (intermittent Theta Burst Stimulation (a patterned form of rTMS). The participants will receive iTBS (50hz bursts at 5Hz for 600 pulses for a total duration of 3-minutes) over the right PPC at 80% RMT of the FDI.
ACTIVE: intermittent Theta Burst Stimulation (a patterned form of rTMS). The participants will receive iTBS (50hz bursts at 5Hz for 600 pulses for a total duration of 3-minutes) over the right PPC at 80% RMT of the FDI.
Eligibility Criteria
You may qualify if:
- a confirmed diagnosis of idiopathic Parkinson's disease
- absence of freezing of gait confirmed by a "No" answer to the second item of the New Freezing of Gait Questionnaire (NFOGQ) and no observation of FOG during a freezing provoking test
- no other neurological diagnosis
- no severe musculoskeletal/orthopedic or vestibular condition that interferes with walking and or significantly affects balance
- no mild cognitive impairment (Montreal Cognitive Assessment ≥ 25)
- able to walk independently and without assistive device for 30 minutes
- no previous experience with split-belt treadmill.
You may not qualify if:
- severe dyskinesia that interacts with walking and balance hearing or visual impairment
- observed inability to walk safely on a tied-belt treadmill
- neurological disorders other than PD or other pathology (e.g., orthopedic) interfering with mobility. - contradiction for TMS
- implanted deep brain stimulator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McGill University - Currie Gymnasium
Montreal, Quebec, H2W 1S4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline Paquette, PhD
McGill University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 26, 2025
First Posted
January 20, 2026
Study Start
November 18, 2025
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
We have a data management plan in place but will make anonymized data available.